- Home
- STRO vs PCM Comparison
STRO vs PCM Comparison
Compare STRO & PCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- PCM
- Stock Information
- Founded
- STRO 2003
- PCM 1993
- Country
- STRO United States
- PCM United States
- Employees
- STRO N/A
- PCM N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- PCM Trusts Except Educational Religious and Charitable
- Sector
- STRO Health Care
- PCM Finance
- Exchange
- STRO Nasdaq
- PCM Nasdaq
- Market Cap
- STRO 94.9M
- PCM 82.0M
- IPO Year
- STRO 2018
- PCM N/A
- Fundamental
- Price
- STRO $0.95
- PCM $6.23
- Analyst Decision
- STRO Hold
- PCM
- Analyst Count
- STRO 7
- PCM 0
- Target Price
- STRO $1.97
- PCM N/A
- AVG Volume (30 Days)
- STRO 1.6M
- PCM 29.1K
- Earning Date
- STRO 11-10-2025
- PCM 01-01-0001
- Dividend Yield
- STRO N/A
- PCM 11.68%
- EPS Growth
- STRO N/A
- PCM N/A
- EPS
- STRO N/A
- PCM N/A
- Revenue
- STRO $104,473,000.00
- PCM N/A
- Revenue This Year
- STRO $65.48
- PCM N/A
- Revenue Next Year
- STRO N/A
- PCM N/A
- P/E Ratio
- STRO N/A
- PCM N/A
- Revenue Growth
- STRO N/A
- PCM N/A
- 52 Week Low
- STRO $0.52
- PCM $6.88
- 52 Week High
- STRO $4.60
- PCM $10.20
- Technical
- Relative Strength Index (RSI)
- STRO 45.59
- PCM 31.29
- Support Level
- STRO $1.01
- PCM $6.25
- Resistance Level
- STRO $1.20
- PCM $6.34
- Average True Range (ATR)
- STRO 0.12
- PCM 0.12
- MACD
- STRO -0.02
- PCM -0.01
- Stochastic Oscillator
- STRO 8.09
- PCM 11.64
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About PCM PCM Fund Inc.
Pcm Fund Inc is a closed-end investment management company. Its investment objective is to seek current income as a primary focus and also capital appreciation. The Fund invests in agency-guaranteed mortgage-backed securities, private-label mortgage-backed securities, high-yield corporate debt securities, and commercial mortgage-backed securities.